Evidence map›Paper›PMID 36476567›Full record

ArticleNeuroImage2023

Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease.

Jingwen Yao, Melanie A Morrison, Angela Jakary, Sivakami Avadiappan, Yicheng Chen, Johanna Luitjens, Julia Glueck, Theresa Driscoll, Michael D Geschwind, Alexandra B Nelson and 3 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Leveraging ultra-high field (7T) MRI in psychiatric research.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Jingwen YaoDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.
Melanie A MorrisonDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.
Angela JakaryDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.
Sivakami AvadiappanDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.
Yicheng ChenDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA; UCSF/UC Berkeley Graduate Program in Bioengineering, San Francisco & Berkeley, CA, USA; Meta Platforms, Inc., Mountain View, CA, USA.
Johanna LuitjensDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Julia GlueckDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
Theresa DriscollDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
Michael D GeschwindDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
Alexandra B NelsonDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
Javier E Villanueva-MeyerDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.
Christopher P HessDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
Janine M LupoDepartment of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA; UCSF/UC Berkeley Graduate Program in Bioengineering, San Francisco & Berkeley, CA, USA. Electronic address: janine.lupo@ucsf.edu.
University of California, San Francisco · USLMU Klinikum · DEMeta (United States) · US

Funding

IMPROVED MONITORING OF PREMANIFEST AND EARLY HUNTINGTONS USING 7T MULTIMODAL MRIR01NS099564 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HESS, CHRISTOPHER PAUL, LUPO, JANINE MARIE · 2017 to 2021
$3.0M
NINDS NIH HHS R01 NS099564
6 · The paper itself

Abstract

Quantitative susceptibility mapping (QSM) is a promising tool for investigating iron dysregulation in neurodegenerative diseases, including Huntington's disease (HD). Many diverse methods have been proposed to generate accurate and robust QSM images. In this study, we evaluated the performance of different dipole inversion algorithms for iron-sensitive susceptibility imaging at 7T on healthy subjects of a large age range and patients with HD. We compared an iterative least-squares-based method (iLSQR), iterative methods that use regularization, single-step approaches, and deep learning-based techniques. Their performance was evaluated by comparing: (1) deviations from a multiple-orientation QSM reference; (2) visual appearance of QSM maps and the presence of artifacts; (3) susceptibility in subcortical brain regions with age; (4) regional brain susceptibility with published postmortem brain iron quantification; and (5) susceptibility in HD-affected basal ganglia regions between HD subjects and healthy controls. We found that single-step QSM methods with either total variation or total generalized variation constraints (SSTV/SSTGV) and the single-step deep learning method iQSM generally provided the best performance in terms of correlation with iron deposition and were better at differentiating between healthy controls and premanifest HD individuals, while deep learning QSM methods trained with multiple-orientation susceptibility data created QSM maps that were most similar to the multiple orientation reference and with the best visual scores.

Indexed as

Huntington DiseaseAlgorithmsBrainBrain MappingHealthy VolunteersHumansImage Processing, Computer-AssistedIronMagnetic Resonance ImagingIronDipole inversionHuntington's disease (HD)Iron imagingMagnetic resonance imaging (MRI)Magnetic susceptibilityQuantitative susceptibility mapping (QSM)

Identifiers

PMID36476567
PMCPMC11588860
OpenAlexW4311448155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.